Connect with us

Business

Starpharma (ASX:SPL) share price surges higher on COVID product update

Published

on

The Starpharma Holdings Limited (ASX: SPL) share price has been a strong performer on Thursday.

At the time of writing, the dendrimer products developer’s shares are up 6% to $1.89.

Why is the Starpharma share price racing higher?

Investors have been buying Starpharma’s shares following the release of an update on its Viraleze antiviral nasal spray.

According to the release, the Viraleze antiviral nasal spray is now available for purchase by consumers in Europe via the company’s webstore.

This follows the recent launch of Viraleze in the United Kingdom through LloydsPharmacy’s 1,400 stores and online business. It is also expected to be available via independent United Kingdom pharmacies later this month.

What is…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

2 exciting ASX tech shares that have been named as buys
Article feature image
Qld on alert after positive COVID-19 case visited airport DFO and Brisbane CBD – Brisbane Times